查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1406754

皮膚科市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、按應用、最終用戶區域和競爭細分

Dermatology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Application, By End User Region and Competition
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球皮膚科市場價值為 13.2 億美元，預計在預測期內將強勁成長，到 2028 年CAGR為6.62%。全球皮膚科市場是一個充滿活力且快速發展的行業，在解決這一問題方面發揮關鍵作用。廣泛的皮膚相關病症和疾病。近年來，由於技術進步、意識增強和人口老化，皮膚科市場出現了大幅成長。該市場涵蓋廣泛的產品和服務，從藥品和生物製劑到診斷設備和美容干預措施。推動皮膚科市場擴張的關鍵驅動力之一是皮膚病發病率的上升，包括皮膚炎、牛皮癬、痤瘡和皮膚癌，這使得對有效治療方案的需求增加。此外，由於消費者對年輕和健康皮膚的渴望不斷增加，對美容手術和美容皮膚學的日益重視對市場成長做出了重大貢獻。

除了傳統治療之外，技術創新也刺激了標靶生物製劑和個人化醫療等新型療法的發展，改變了皮膚病護理的模式。市場正在見證研發活動的激增，促進創新療法和治療方式的發現。從地理位置來看，由於先進的醫療基礎設施、皮膚病的高發病率以及積極主動的護膚方法，北美和歐洲傳統上佔據著巨大的市場佔有率。然而，在中產階級人口不斷擴大、可支配收入增加以及皮膚健康意識不斷提高的推動下，亞太和拉丁美洲的新興經濟體正在迅速獲得關注。

合作、夥伴關係和策略收購是產業參與者加強市場立足點和擴大產品組合的普遍策略。總體而言，在人口趨勢、技術進步和不斷變化的消費者偏好的共同推動下，全球皮膚科市場有望持續成長，使其成為更廣泛的醫療保健行業中至關重要且充滿活力的部門。

市場概況
預測期 2024-2028
2022 年市場規模 13.2億美元
2028 年市場規模 19.3億美元
2023-2028 年CAGR 6.62%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

主要市場促進因素

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：全球皮膚科市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（醫學皮膚病學、外科皮膚病學、小兒皮膚病學、美容皮膚病學、皮膚淋巴瘤、皮膚免疫學、其他）
    • 按應用（痤瘡、皮膚炎、牛皮癬、皮膚癌、紅斑痤瘡、脫髮等）
    • 按最終使用者（醫院和診所、門診手術中心、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖
    • 按類型
    • 按應用
    • 按最終用戶
    • 按地區

第 5 章：亞太皮膚科市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國皮膚科
    • 印度皮膚科
    • 澳洲皮膚科
    • 日本皮膚科
    • 韓國皮膚科

第 6 章：歐洲皮膚科市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美皮膚科市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲皮膚科市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲皮膚科市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非皮膚科
    • 沙烏地阿拉伯皮膚科
    • 阿拉伯聯合大公國皮膚科
    • 埃及皮膚科

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球皮膚科市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • 艾伯維公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Current Capacity Analysis
    • Financials (In case of listed)
    • Recent Developments
    • SWOT Analysis
  • 輝瑞公司
  • 葛蘭素史克公司
  • 利奧製藥公司
  • 太陽製藥工業有限公司
  • 高德美公司
  • 安進公司
  • 德姆比恩特公司
  • 強生服務公司
  • 魯瓦特科學有限公司

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 19873

Global Dermatology Market has valued at USD 1.32 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 6.62% through 2028. The global dermatology market is a dynamic and rapidly evolving sector that plays a pivotal role in addressing a wide array of skin-related conditions and disorders. Characterized by a robust combination of technological advancements, increasing awareness, and a growing aging population, the dermatology market has witnessed substantial growth in recent years. The market encompasses a broad spectrum of products and services, ranging from pharmaceuticals and biologics to diagnostic devices and cosmetic interventions. One of the key drivers fueling the expansion of the dermatology market is the rising incidence of skin diseases, including dermatitis, psoriasis, acne, and skin cancer, necessitating a heightened demand for effective treatment options. Furthermore, the growing emphasis on aesthetic procedures and cosmetic dermatology has contributed significantly to market growth, driven by the increasing consumer desire for youthful and healthy skin.

In addition to traditional treatments, technological innovations have spurred the development of novel therapies, such as targeted biologics and personalized medicine, transforming the landscape of dermatological care. The market is witnessing a surge in research and development activities, fostering the discovery of innovative therapies and treatment modalities. Geographically, North America and Europe have traditionally held substantial market shares, owing to advanced healthcare infrastructure, a high prevalence of skin disorders, and a proactive approach to skincare. However, emerging economies in Asia-Pacific and Latin America are rapidly gaining traction, driven by an expanding middle-class population, rising disposable income, and increasing awareness about dermatological health.

Collaborations, partnerships, and strategic acquisitions are prevalent strategies among industry participants to strengthen their market foothold and expand their product portfolios. Overall, the global dermatology market is poised for continued growth, fueled by a combination of demographic trends, technological advancements, and evolving consumer preferences, making it a vital and vibrant sector within the broader healthcare industry.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.32 Billion
Market Size 2028USD 1.93 Billion
CAGR 2023-20286.62%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Key Market Drivers

Increasing Incidence of Skin Disorders Worldwide

The global dermatology market is witnessing a substantial boost, driven in large part by the increasing incidence of skin disorders worldwide. Skin conditions, ranging from common ailments like dermatitis and acne to more serious issues such as psoriasis and skin cancer, have become more prevalent across diverse demographics. This upsurge can be attributed to a combination of factors, including environmental changes, lifestyle choices, and genetic predispositions. As the global population expands and ages, there is a parallel rise in the demand for effective dermatological treatments and interventions.

The prevalence of skin disorders has become a significant public health concern, prompting a heightened focus on dermatology as a crucial facet of healthcare. Skin conditions not only impact physical well-being but also carry a substantial psychological and emotional burden. This has led to an increased awareness among individuals about the importance of seeking professional dermatological care, thereby driving the demand for dermatological products and services. As a result, the pharmaceutical industry is responding with a growing array of medications, including topical treatments, oral medications, and biologics, designed to address specific skin conditions and improve patient outcomes.

The surge in skin disorders is also influencing the development of advanced diagnostic technologies and treatment modalities within the dermatology market. Innovations such as telemedicine and digital health platforms are facilitating improved access to dermatological expertise, enabling patients to seek consultations remotely. Moreover, the integration of artificial intelligence and machine learning in dermatological diagnostics is enhancing the accuracy and efficiency of disease detection. Early diagnosis is crucial in managing skin disorders effectively, and these technological advancements contribute significantly to the overall growth and competitiveness of the dermatology market.

The global dermatology market is witnessing a paradigm shift not only in response to the increasing prevalence of skin disorders but also due to changing societal perceptions. The recognition of the impact of skin conditions on quality of life has fueled a growing demand for cosmetic dermatology procedures. Individuals are seeking aesthetic treatments to address concerns related to aging, pigmentation, and overall skin appearance. This burgeoning interest in cosmetic interventions, including injectables, laser therapies, and surgical procedures, is opening new avenues for dermatologists and contributing to the diversification of the dermatology market.

Technological Advancements

Technological advancements are playing a transformative role in propelling the global dermatology market to new heights. The integration of cutting-edge technologies has significantly enhanced the diagnosis, treatment, and overall management of dermatological conditions, fostering a paradigm shift in healthcare solutions. One of the notable contributions comes from the realm of telemedicine and digital health platforms, which have revolutionized the way dermatological care is delivered. These technologies enable remote consultations, allowing patients to access specialized dermatological expertise regardless of geographical barriers. This not only enhances patient convenience but also facilitates timely interventions and reduces the burden on traditional healthcare infrastructures.

In the field of diagnostics, technological innovations have brought about remarkable improvements in accuracy and efficiency. Techniques such as dermoscopy and reflectance confocal microscopy have revolutionized skin cancer diagnosis, providing dermatologists with powerful tools for early detection and precise assessment. Artificial intelligence (AI) and machine learning algorithms are being increasingly employed to analyze dermatological images, assisting in the identification of patterns indicative of various skin conditions. This not only aids in faster and more accurate diagnostics but also contributes to the overall efficiency of dermatological care.

Moreover, advancements in treatment modalities are reshaping the therapeutic landscape of dermatology. Targeted biologics, personalized medicine, and innovative pharmaceuticals are emerging as more effective and precise interventions for various skin disorders. These developments signify a shift toward customized treatment plans, addressing individual patient needs and characteristics. The market is witnessing a surge in research and development activities aimed at discovering novel therapies that leverage the latest scientific and technological breakthroughs, thereby expanding the array of options available to dermatologists and their patients.

The incorporation of technology also extends to patient education and engagement. Digital platforms and mobile applications provide valuable resources for individuals seeking information on skincare, preventive measures, and treatment options. These tools empower patients to actively participate in their dermatological care, fostering a collaborative approach between healthcare providers and patients. The increased accessibility to information contributes to heightened awareness about skin health, leading to proactive measures and early intervention.

Increasing Awareness of Aesthetic Dermatology Procedures

The global dermatology market is experiencing a significant uplift driven by the increasing awareness of aesthetic dermatology procedures. Aesthetic concerns and the desire for enhanced physical appearance have become prominent factors influencing consumer choices in the realm of dermatological interventions. Individuals are increasingly seeking cosmetic dermatology procedures to address a variety of aesthetic issues, including signs of aging, pigmentation irregularities, and overall skin quality. This heightened awareness is fueling a surge in demand for a diverse range of aesthetic treatments, ranging from minimally invasive procedures such as injectables and laser therapies to more extensive surgical interventions.

The growing acceptance of aesthetic dermatology is reshaping the market dynamics, with a notable shift in consumer preferences towards treatments that offer natural-looking results and minimal downtime. The market response to this trend has been the development of advanced and innovative cosmetic interventions designed to cater to diverse patient needs. Injectables like botulinum toxin and dermal fillers are witnessing a robust demand, providing non-surgical options for facial rejuvenation and volume restoration. Laser and light-based therapies are gaining popularity for addressing skin imperfections and promoting collagen production. Additionally, surgical procedures such as facelifts and body contouring are becoming more commonplace as individuals seek comprehensive solutions for aesthetic enhancement.

The rise in awareness of aesthetic dermatology is not only influencing individual choices but is also driving the growth of specialized dermatology practices and clinics dedicated to cosmetic procedures. Dermatologists and healthcare professionals are adapting to this evolving landscape by expanding their expertise and offering a broader array of aesthetic services. The market is witnessing a convergence of medical and cosmetic dermatology, with practitioners adopting a holistic approach to address both medical and aesthetic concerns, thereby catering to the diverse needs of their patient base.

Furthermore, the influence of social media and digital platforms is playing a pivotal role in spreading awareness about aesthetic dermatology procedures. Before-and-after photos, patient testimonials, and educational content shared on these platforms contribute to an informed and engaged audience. Patients are increasingly researching and seeking information online, leading to a more educated consumer base that actively participates in decisions related to their aesthetic treatments.

Key Market Challenges

Economic Burden Associated with Dermatological Treatments

The economic burden associated with dermatological treatments stands out as a significant impediment hindering the global dermatology market. As the market witnesses the emergence of cutting-edge therapies, including biologics and advanced pharmaceuticals, the high costs of research, development, and production contribute to elevated pricing, limiting accessibility for a substantial portion of the population.

In developed countries, where healthcare resources are relatively abundant, the economic challenge manifests in the form of high out-of-pocket expenses for patients seeking dermatological care. The affordability of these treatments becomes a pressing concern, especially for those without comprehensive insurance coverage. This economic barrier not only restricts patient access to innovative therapies but also places a strain on healthcare systems, leading to disparities in the quality of dermatological care based on socioeconomic factors.

In developing nations, the economic burden poses an even more formidable challenge. Limited healthcare resources and infrastructure, coupled with a lack of insurance coverage, make advanced dermatological treatments a luxury rather than a necessity for many individuals. Skin disorders, which can significantly impact quality of life, often go untreated due to financial constraints. This not only results in prolonged suffering for affected individuals but also contributes to the overall burden of untreated dermatological conditions on public health.

Regulatory hurdles

Regulatory hurdles are a formidable obstacle impeding the seamless growth of the global dermatology market. The journey from the inception of innovative dermatological products to their commercialization is often prolonged and arduous due to stringent regulatory requirements. While these regulations are crucial for ensuring the safety and efficacy of dermatological treatments, the complex and time-consuming approval processes can significantly delay the introduction of novel solutions to the market.

The regulatory landscape for dermatological products is characterized by rigorous testing and documentation requirements. Pharmaceutical companies and manufacturers must adhere to strict protocols to demonstrate the safety and effectiveness of their products before gaining regulatory approval. This meticulous approach, while essential for protecting patient well-being, inevitably extends the time and resources required for bringing new dermatological therapies to market.

Additionally, the divergent regulatory standards across different regions and countries present a significant challenge for industry players aiming for global market penetration. Navigating the intricacies of varied regulatory frameworks demands substantial investments in legal and regulatory affairs expertise, further complicating the pathway to market approval. The variations in regulatory standards not only extend the timelines for product approvals but also create barriers to entry, limiting the accessibility of innovative dermatological treatments for patients in certain regions.

Key Market Trends

Surge in Cosmetic Procedures and Dermatological Surgeries

The global dermatology market is experiencing a surge driven by the increasing demand for cosmetic procedures and dermatological surgeries. This trend is indicative of a cultural shift where individuals are placing a higher emphasis on aesthetic enhancements and skin rejuvenation. Non-invasive cosmetic procedures, such as injectables (e.g., dermal fillers and neurotoxins like Botox) and laser therapies, have become immensely popular due to their effectiveness in addressing signs of aging and enhancing facial features. The allure of these minimally invasive treatments lies in their ability to deliver noticeable results with minimal downtime, catering to individuals seeking quick and convenient solutions for aesthetic improvements.

Dermatological surgeries, including facelifts, eyelid surgery, and liposuction, are also on the rise. These procedures offer more comprehensive and long-lasting results, addressing a range of concerns beyond what non-invasive treatments can achieve. The increasing acceptance and destigmatization of cosmetic procedures contribute to a growing patient pool opting for dermatological surgeries to achieve their desired aesthetic outcomes. Moreover, advancements in surgical techniques and technology have made these procedures safer and more accessible, attracting a broader demographic of patients.

The surge in cosmetic procedures and dermatological surgeries is driven by a desire for enhanced self-esteem and confidence, coupled with a societal appreciation for aesthetic diversity. As the global population ages, there is a heightened awareness of the impact of aging on one's appearance, fueling the demand for anti-aging solutions. The influence of social media, where visual representation holds significant value, further contributes to the popularity of cosmetic interventions.

Technological Integration in Teledermatology

The global dermatology market is experiencing a significant boost propelled by the integration of technology, particularly in the realm of teledermatology. This innovative approach to dermatological care involves the use of digital platforms and telecommunication technologies to facilitate remote consultations, diagnosis, and treatment planning. The convergence of technology and dermatology not only addresses barriers to traditional healthcare access but also enhances the overall efficiency and reach of dermatological services.

Teledermatology is reshaping patient care by allowing individuals to consult with dermatologists from the comfort of their homes. This is particularly advantageous in areas with limited access to specialized dermatological services or during situations like the COVID-19 pandemic, where in-person visits may be challenging. The integration of high-quality imaging tools, such as dermoscopes, enables patients to capture and share images of skin conditions with dermatologists, facilitating accurate and timely remote assessments.

Furthermore, the rise of artificial intelligence (AI) and machine learning in teledermatology is revolutionizing the diagnostic process. These technologies analyze dermatological images, aiding in the identification of patterns indicative of various skin conditions. The automation of certain diagnostic tasks not only enhances the accuracy of assessments but also expedites the overall diagnostic process, contributing to timely and effective patient care.

The global adoption of teledermatology is facilitated by the increasing prevalence of smartphones and internet connectivity. Mobile applications and telehealth platforms dedicated to dermatology provide patients with user-friendly interfaces, allowing them to schedule virtual appointments, share images securely, and receive expert guidance. This technological integration not only improves patient convenience but also fosters a proactive approach to skincare, as individuals can seek dermatological advice promptly.

Segmental Insights

Application Insights

Based on the Application, Acne emerged as the dominant segment in the global market for Global Dermatology in 2022. Acne is one of the most prevalent skin conditions globally. It affects individuals of various age groups, and its widespread occurrence drives the demand for effective treatments. The condition can range from mild to severe, leading individuals to seek dermatological care for personalized solutions. Acne can have a profound psychosocial impact, affecting self-esteem and quality of life. Individuals often seek dermatological interventions not only for the physical symptoms but also to address the emotional and psychological aspects associated with acne. This contributes to a sustained demand for acne-related treatments. Increasing awareness about skincare and dermatological health has led individuals to proactively seek solutions for acne.

Type Insights

Based on the Type, Cosmetic Dermatology emerged as the dominant segment in the global market for Global Dermatology Market in 2022. The increasing emphasis on aesthetic concerns and the desire for cosmetic enhancements contribute significantly to the popularity of cosmetic dermatology procedures. As societal attitudes evolve, there is a growing acceptance and destigmatization of cosmetic interventions, leading to a surge in demand for treatments that address signs of aging, pigmentation issues, and overall skin appearance.The appeal of cosmetic dermatology lies in its ability to offer non-invasive or minimally invasive procedures that yield visible and often immediate results.

Regional Insights

North America emerged as the dominant player in the Global Dermatology Market in 2022, holding the largest market share. The cultural emphasis on aesthetics and youthfulness has driven a significant demand for cosmetic dermatology procedures. North America leads in the adoption of cosmetic interventions, including injectables, laser therapies, and other aesthetic treatments, contributing substantially to the overall dermatology market. The region is home to numerous pharmaceutical and biotechnology companies actively engaged in dermatology research and development. Ongoing efforts to innovate and introduce new therapeutic options have propelled North America to the forefront of dermatological advancements.

Key Market Players

AbbVie Inc.

Pfizer Inc.

GSK plc

LEO Pharma A/S

Sun Pharmaceutical Industries Ltd

Galderma S.A.

Amgen Inc.

DermBiont, Inc.

Johnson & Johnson Services Inc.

Roivant Sciences Ltd

Report Scope:

In this report, the Global Dermatology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Dermatology Market, By Type:

  • Medical Dermatology
  • Surgical Dermatology
  • Pediatric Dermatology
  • Cosmetic Dermatology
  • Cutaneous Lymphoma
  • Dermatoimmunology
  • Others

Global Dermatology Market, By Application:

  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Cancer
  • Rosacea
  • Alopecia
  • Others

Global Dermatology Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Global Dermatology Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Dermatology Market.

Available Customizations:

  • Global Dermatology Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Dermatology Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Others)
    • 4.2.2. By Application (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, Others)
    • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Type
    • 4.3.2. By Application
    • 4.3.3. By End User
    • 4.3.4. By Region

5. Asia Pacific Dermatology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Dermatology Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Type
        • 5.3.1.2.2. By Application
        • 5.3.1.2.3. By End User
    • 5.3.2. India Dermatology Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Type
        • 5.3.2.2.2. By Application
        • 5.3.2.2.3. By End User
    • 5.3.3. Australia Dermatology Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Type
        • 5.3.3.2.2. By Application
        • 5.3.3.2.3. By End User
    • 5.3.4. Japan Dermatology Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Type
        • 5.3.4.2.2. By Application
        • 5.3.4.2.3. By End User
    • 5.3.5. South Korea Dermatology Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Type
        • 5.3.5.2.2. By Application
        • 5.3.5.2.3. By End User

6. Europe Dermatology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Dermatology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Germany Dermatology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Spain Dermatology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User
    • 6.3.4. Italy Dermatology Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End User
    • 6.3.5. United Kingdom Dermatology Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End User

7. North America Dermatology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Dermatology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico Dermatology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada Dermatology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. South America Dermatology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Dermatology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Argentina Dermatology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Colombia Dermatology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User

9. Middle East and Africa Dermatology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Dermatology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Saudi Arabia Dermatology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. UAE Dermatology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. Egypt Dermatology Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Dermatology Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. AbbVie Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Pfizer Inc.
  • 14.3. GSK plc
  • 14.4. LEO Pharma A/S
  • 14.5. Sun Pharmaceutical Industries Ltd
  • 14.6. Galderma S.A.
  • 14.7. Amgen Inc.
  • 14.8. DermBiont, Inc.
  • 14.9. Johnson & Johnson Services Inc.
  • 14.10. Roivant Sciences Ltd

15. Strategic Recommendations

16. About Us & Disclaimer